Immediate and LAte Adverse Reactions in Coronary Angiography
| Autor: | Sven-Göran Fransson, M. Andersson, G. Stenport |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Male
Coronary angiography medicine.medical_specialty Diastole Contrast Media Hemodynamics Coronary Disease Coronary Angiography 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Left coronary artery Double-Blind Method Triiodobenzoic Acids Internal medicine medicine.artery Ioxaglic Acid medicine Humans Radiology Nuclear Medicine and imaging Myocardial infarction Adverse effect Radiological and Ultrasound Technology business.industry Parallel study General Medicine Middle Aged medicine.disease Iodixanol 030220 oncology & carcinogenesis Cardiology Female business medicine.drug |
| Zdroj: | Acta Radiologica. 37:218-222 |
| ISSN: | 1600-0455 0284-1851 |
| DOI: | 10.1177/02841851960371p145 |
| Popis: | Purpose and Methods: In 120 patients in a double-blind, randomized, parallel study, iodixanol (Visipaque), a nonionic dimer isotonic with blood, was compared with ioxaglate (Hexabrix), an ionic low-osmolar dimer, in coronary angiography regarding early and late adverse reactions. Haemodynamic and electrophysiologic parameters were also analyzed. Results: Visipaque resulted in significantly fewer early adverse contrast medium-related reactions (pConclusion: We found Visipaque safe for coronary angiography, causing fewer early adverse reactions than Hexabrix and also fewer effects on electrophysiologic parameters. Late adverse reactions seemed to be unusual with intra-arterial administration of contrast media. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|